lawson. so the so that is that is a completely different system that's an idea of a completely different system before we move on from the from the concept not the concept but move on from patients from call the vaccine patients what impact would undermining these patients or giving free access to these patients what impact would that have on future research do you think. oh i think we already have a broken system so we could question the validity of the system as a whole but even if we see this as an exceptional moment and this is a 1000 a century human experience or as the head of the w. has said about this issue if not now when i mean we suspended patents for the aids that didn't destroy the patent system but it kept many many people alive myself i would like to see wider reform of the patent system i agree with thomas didn't know if it is a system that rewards investment in invite them and there is a system that has been broken for many many many years so i think that remains true but eve

let them bring in our guest joining us from london is max lawson who is the head of inequality policy at oxfam international and with us from new delhi is russia. on an intellectual property lawyer and legal counsel for not co pharma and joining us from barcelona is jeffrey lazarus who's the head of the health systems research group at the barcelona institute for global health thanks for joining us welcome to inside story max let me start with you you say there is huge support to remove intellectual property or ip and this movement is gaining ground when it comes to the coronavirus vaccine tell us why you say that and what you're basing that on well i think when you see that number of countries now supporting example pricker in india the government yard 100 countries you're seeing people at the party print a very private group we're hearing brontë this. things that cracks are appearing in some of the richer countries governments nancy pelosi had of the democrats in the senate came out in favor of just last week so i think we are seeing momentum building and it's no surprise really be

let them bring in our guest joining us from london is max lawson who is the head of inequality policy at oxfam international and with us from new delhi is russia. on an intellectual property lawyer and legal counsel for not co pharma and joining us from barcelona is jeffrey lazarus who's the head of the health systems research group at the barcelona institute for global health thanks for joining us welcome to inside story max let me start with you you say there is huge support to remove intellectual property or ip and this movement is gaining ground when it comes to the coronavirus vaccine tell us why you say that and what you're basing that on well i think when you see that number of countries now supporting example pricker in india the government yard 100 countries you're seeing people at the party print a very private group we're hearing brontë this. things that cracks are appearing in some of the rich country governments nancy pelosi had of the democrats in the senate came out in favor of just last week so i think we are seeing momentum building and it's no surprise really becaus

lawson. so the so that is that is a completely different system that's an idea of a completely different system before we move on from the from the concept not the concept but move on from patients from cover vaccine patients what impact would undermining these patients or giving free access to these patients what impact would that have on future research do you think. so i think we already have a broken system so we could question the validity of the system as a whole but even if we see this as an exceptional moment and this is 1000 a century human experience or as the head of the w. has said about this issue if not now when i mean we suspended patents for the aids that didn't destroy the patent system but it kept many many people alive myself i would like to see wider reform of the patent system i agree with thomas didn't know if it is a system that rewards investment in invite them and there is a system that has been broken for many many many years so i think that remains true but even if

let them bring in our guest joining us from london is max lawson who is the head of inequality policy at oxfam international and with us from new delhi is russia. on an intellectual property lawyer and legal counsel for not co pharma and joining us from barcelona is jeffrey lazarus is the head of the health systems research group at the barcelona institute for global health thanks for joining us welcome to inside story max let me start with you you say there is huge support to remove intellectual property or ip and this movement is gaining ground when it comes to the coronavirus vaccine tell us why you say that and what you're basing that on well i think when you see that number of countries now supporting example for current india the government yard 100 countries you're saying people at the party print a very private group we're hearing drawing this. things that cracks are appearing in some of the richer country governments nancy pelosi of the democrats in the senate came out in favor of just last week so i think we are seeing momentum building and it's no surprise really because th

lawson is head of inequality policy at oxfam international very well welcome to the program thanks for joining us here on inside story i'd like to begin with you samantha america as we read saying is about to receive control of a patient of basically the technology which is at the heart of several coronavirus vaccines can you explain that for us and what it might be. so i think we have already lost some opportunities to apply pressure on pharma companies to open license and we know that already but there there is a chance that the governments like the u.s. can now apply pressure to have more transfer of technology through their ownership on things like this. so this patent is i guess molecular engineering this is this is being described as the last best chance that we have for equitable access what do you think thomas pogge do you think this is the world's last best chance do you think that the world will take it will the us use this opportunity to pressure the drug makers. but i don't think it's the only chance that we have a key objective so we have to increase production and we have